IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Capital expenditures 2016–2025
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$33.8MFY2025 · since FY2016: $1.5M → $33.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $33.8M | +205.7% |
| FY2024 | $11.1M | -50.3% |
| FY2023 | $22.3M | +9.1% |
| FY2022 | $20.4M | -45.6% |
| FY2021 | $37.6M | -19.7% |
| FY2020 | $46.8M | +576.5% |
| FY2019 | $6.9M | +477.4% |
| FY2018 | $1.2M | +16.5% |
| FY2017 | $1.0M | -32.4% |
| FY2016 | $1.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice